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Graphical abstract 
 
Q fever is endemic throughout the world, but remains a largely neglected infection in Africa, 
where there is a need for systematic molecular epidemiological studies. 
 
 
 
 
Highlights 
 Q fever is a bacterial zoonotic disease 
 Acquired mainly from livestock 
 The infection is endemic in Africa but studies are largely restricted to serology 
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 Analysis of bacterial genotype is key to understanding transmission and pathogenesis 
 There is a need for systematic molecular epidemiological studies in Africa 
 
 
 
Abstract 
Q fever is a bacterial worldwide zoonosis (except New Zealand) caused by the Gram-negative 
obligate intracellular bacterium Coxiella burnetii (C. burnetii). The bacterium has a large host 
range including arthropods, wildlife and companion animals and is frequently identified in 
human and livestock populations. In humans, the disease can occur as either a clinically acute 
or chronic aetiology, affecting mainly the lungs and liver in the acute disease, and heart valves 
when chronic. In livestock, Q fever is mainly asymptomatic; however, the infection can cause 
abortion, and the organism is shed in large quantities, where it can infect other livestock and 
humans. The presence of Q fever in Africa has been known for over 60 years, however while 
our knowledge of the transmission routes and risk of disease have been well established in 
many parts of the world, there is a significant paucity of knowledge across the African 
continent, where it remains a neglected zoonosis. Our limited knowledge of the disease across 
the African sub-continent have relied largely upon observational (sero) prevalence studies with 
limited focus on the molecular epidemiology of the disease. This review highlights the need 
for systematic studies to understand the routes of C. burnetii infection, and understand the 
disease burden and risk factors for clinical Q fever in both humans and livestock. With such 
knowledge gaps filled, the African continent could stand a better chance of eradicating Q fever 
through formulation and implementation of effective public health interventions.  
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1. Introduction 
Q fever is a zoonotic disease with a worldwide distribution except for New Zealand and 
Antarctica. The first identification of Q fever or ‘Query fever’ was published in 1937 (Derrick, 
1937). However, Q fever remained a relatively neglected disease, until the recent national 
outbreak in the Netherlands between 2007 and 2010, which demonstrated the potential of the 
disease to be a major public health issue (Schneeberger et al., 2014).   
The causative agent of Q fever is the bacterium Coxiella burnetii, a category B 
bioterrorism agent. C. burnetii has a wide host range including humans, ruminants (goats, 
sheep, and cattle), as well as companion animals and ticks. In livestock, C. burnetii infection 
remains often clinically inapparent, except in cases of abortion, particularly in goats and sheep 
(Van den Brom et al., 2015b). In humans, infection can cause an acute form of disease, which 
typically exhibits itself as pneumonia and a chronic form resulting in endocarditis, which is 
potentially fatal (Gikas et al., 2010).  
In recent years, our understanding of the transmission of Q fever has been transformed 
by the use of molecular typing techniques. However, our knowledge has remained largely 
defined by studies in Europe and North America. The presence of Q fever in Africa has been 
recognised for over 60 years (Kaplan and Bertagna, 1955), however it remains a relatively 
neglected zoonosis across the continent, and our knowledge of the disease across the continent 
is largely through serology and sero-epidemiological studies. The purpose of this review is to 
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provide a general overview of the Q fever bacteriology, pathology, and infection of relevant 
host, reservoirs and transmission as well as existing genotyping techniques. Most significantly, 
a special focus is given to revealing the lack of systematic and comprehensive studies of the 
molecular epidemiology of Q fever in Africa. 
 
2. Clinical Q fever 
2.1 Human infection 
Clinical manifestation of Q fever occurs as either an acute or a chronic form of disease. 
Approximately 40 % of infected people will develop symptomatic acute Q fever of which, the 
majority will present as a non-specific, self-limiting illness. More severe clinical symptoms 
include fever, headache, chills, atypical pneumonia and hepatitis,(Derrick, 1973; Maurin and 
Raoult, 1999; Raoult et al., 2005). Acute episodes are rarely fatal unless the patients also 
suffered from severe underlying medical conditions (Kampschreur et al., 2010). 
Approximately 20 % of acute Q fever sufferers experience symptoms of long-term fatigue, 
which frequently lasts beyond a year and more commonly between 5 to 10 years after the initial 
episode. This is termed post Q fever fatigue syndrome (QFS) and while the symptoms are 
poorly defined, sufferers experience significant long-term impaired health status and reduced 
quality of life (Morroy et al., 2016). Chronic Q fever develops in less than 5 % of patients in 
which symptoms may only manifest years after the initial infection. Clinical symptoms include 
non-specific fatigue, fever, weight loss, night sweats and hepato-splenomegaly as well as 
endocarditis (Raoult et al., 2005; Wegdam-Blans et al., 2012). After the recent outbreak in the 
Netherlands, vascular complications appeared to be more common than endocarditis, however 
due to the relatively short period of time since the outbreak and the slow clinical progression 
of disease, endocarditis may not have become apparent yet in many chronically infected 
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individuals (van der Hoek et al., 2012). Chronic Q fever has a wider clinical presentation and 
has recently been recommended to undergo a nosological refinement to accommodate all 
probable manifestations, for a better clinical diagnosis (Eldin et al., 2017). 
 
2.2 The role of livestock in the transmission of Q fever 
While C. burnetii infects a number of animal species, the majority of human infections 
are thought to be associated with livestock, although infection through contact with wildlife 
(kangaroos, wallabies and three-toed sloth) (Davoust et al., 2014; Eldin et al., 2015; Maurin 
and Raoult, 1999), and companion animals (Buhariwalla et al., 1996; Komiya et al., 2003; 
Kopecny et al., 2013; Kosatsky, 1984; Langley et al., 1988; Laughlin et al., 1991; Malo et al., 
2018; Marrie et al., 1988; Pinsky et al., 1991), have been reported. In Infected livestock, the 
bacteria may be shed in significant quantities in birth products, vaginal mucus, urine, faeces, 
or milk. The bacterium is highly infectious (1-10 bacteria) therefore this high bacterial load in 
birth products is a potent source of infection.  
In non-pregnant livestock, C. burnetii infection is virtually asymptomatic. The most 
important clinical presentations of Q fever in livestock species are reproductive anomalies such 
as, abortion, stillbirth, infertility, endometritis, and mastitis. Q fever primarily causes abortion 
in goats, sheep and less commonly in cattle. The highest concentrations of C. burnetii (up to 
109 organisms per gram of tissue) are found in the placentas of infected livestock, either after 
abortion or indeed after livebirth (Berri et al., 2001; Guatteo et al., 2011; Hatchette et al., 2003; 
Lang et al., 1991; Rousset et al., 2009; van Moll et al., 1993). Abortion occurs most frequently 
at the end of gestation, without any preceding clinical symptoms (Arricau-Bouvery et al., 
2005). In goats, abortion, stillbirth but also the birth of strong and lively kids can occur after Q 
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fever infection of pregnant animals (Arricau-Bouvery et al., 2005; Roest et al., 2012). The 
cause of differences in pregnancy outcome between ruminant species is unknown.  
The organism is highly stable in the environment, and due to its resistance to 
desiccation, infectious organisms may be present for many months after shedding, both in the 
immediate environment but also on the wool of infected animals (Wattiau et al., 2011). In 
humans, the primary route of infection is via inhalation of contaminated aerosols, and the 
majority of human infections are primarily the result of contact with infected livestock. 
Evidence suggests that close proximity to the source (the goat birthing pen) is the major risk 
factor associated with infection, and that human activity is largely responsible for the transfer 
of the infective organisms away from the initial source of infection (Kersh et al., 2013a). 
However, aerosolised transmission between infected and naïve herds, or the human population 
and are frequent and often associated with specific environmental conditions, which favour 
dispersal, including wind, and the topography of the landscape (Mori and Roest, 2018). High 
wind speeds, open landscapes, high animal densities, and high temperatures were identified as 
risk factors for transmission of Q fever between Swedish dairy cattle herds (Nusinovici et al., 
2017). Likewise, in France, a correlation between human cases of Q fever, high sheep densities 
and the prevailing Mistral wind has been observed (Tissot-Dupont et al., 2004; Tissot-Dupont 
et al., 1999). Low consistent wind speed in a flat area of the North Brabant region of the 
Netherlands was identified as favourable towards the dispersal and transmission of C. burnetii 
to the local population(van Leuken et al., 2015). 
While inhalation is the most significant route of C. burnetii infection, given the 
prevalence of C. burnetii in milk, dietary ingestion has been studied as a potential route of 
transmission. Mammals shed C. burnetii in milk, and a number of studies have demonstrated 
the presence of C. burnetii DNA in milk  and dairy products  from cattle (Bauer et al., 2015; 
Olivas et al., 2016; Pearson et al., 2014; Velasova et al., 2017), goats (Ceglie et al., 2015; Van 
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den Brom et al., 2015a) and sheep (Barkallah et al., 2014). A high rate of C. burnetii 
seropositivity was demonstrated in humans consuming raw goat’s milk (Eldin et al., 2013).  
However, there is an increased likelihood that individuals accessing raw products live in a rural 
setting, and more likely to be exposed to other potential routes of infection, such as contact 
with livestock. Despite the widespread shedding of C. burnetii in milk, ingestion of dairy 
products are not seen as a primary route of transmission (Eldin et al., 2013; Gale et al., 2015).  
 
2.3 Human to human transmission 
Q fever is thought to be non-communicable, however human-to-human transmission 
can occur, albeit rarely. As with livestock, birth products from infected women may be a source 
of infection, to both hospital staff (Raoult and Stein, 1994), and other pregnant women within 
the same unit (Amit et al., 2014). There is also evidence for sexual transmission (Milazzo et 
al., 2001) and transmission via blood transfusion is a potential risk. C. burnetii is stable in 
blood samples for at least six weeks at 1-6°C (Kersh et al., 2013b). In a recipient tracing study 
of blood donors from the Dutch outbreak of 2009, a transfusion recipient in a highly infected 
area was found to be seropositive after receiving blood from a C. burnetii positive donor (van 
Kraaij et al., 2013).  While in this case, the source of infection cannot be categorically 
determined and the risks of transmission via blood products has been estimated to be low (Oei 
et al., 2014), infection via this route cannot be ruled out.   
 
2.4 The potential role of arthropods in Q fever transmission 
Coxiella burnetii has been identified in over 40 hard bodied and 14 soft bodied species 
of tick (Eldin et al., 2017) isolated form a wide range of animal host species. Indeed the Nine 
Mile strain of C. burnetii was first isolated in 1935 from the tick Dermacentor andersoni in 
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Montana (Davis et al., 1938). Experimentally, successful tick to animal transmission of C. 
burnetii has been demonstrated in a guinea-pig model of infection (Siroky et al., 2010). 
However, it is under debate whether ticks play a significant role in the transmission of C. 
burnetii, or whether the presence of the bacteria in the tick population is simply a reflection for 
C. burnetii prevalence in the tick’s host species. In the Netherlands’ outbreak, ticks were not 
thought to play a significant role in transmission (Sprong et al., 2012). A recent study of 
Spanish Ibex suggested that ticks may play a potential role as a vector of infection but 
modelling suggested a complex interaction between that host, population and environmental 
factors as drivers of infection in ticks (Varela-Castro et al., 2018). 
 
3. Q fever in Africa 
Cases of Q fever have been documented in the African continent for over 60 years.  Q 
fever is an endemic infection across the continent yet we still know relatively little about the 
prevalence and routes of infection or the health impact of the disease in both livestock and 
humans. One of the reasons behind this relative paucity of information, and a major barrier 
towards understanding the impact Q fever is the non-specific nature of symptoms, which are 
commonly confused for other endemic infections including malaria (Crump, 2014). The was 
highlighted in a recent ‘OneHealth’ systematic review (Vanderburg et al., 2014) of Q fever in 
Africa, which came to the conclusion that ‘C. burnetii presents a real yet underappreciated 
threat to human and animal health in Africa’.  
 
3.1 Prevalence in Humans  
In 1955, the first cases of Q fever were reported in nine countries across the African 
continent (Kaplan and Bertagna, 1955). Since then a number of studies have demonstrated that 
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the infection is endemic across the continent, but with significant variation in prevalence 
between countries ranging from 1 % in Chad (Schelling et al., 2003), to 32 % in the Nile Delta 
in Egypt (Corwin et al., 1993).  
Serological evidence of Q fever has been demonstrated in both adults and children; 
however, rates of C. burnetii seropositivity appear higher among young children. High rates of 
seropositivity in children were observed in Ghana’s rural Ashanti Region, where 17 % of two-
year-olds were found to be seropositive (Kobbe et al., 2008). In Niger, 10 % of children aged 
between 1 month old and 5 years of age were seropositive (Julvez et al., 1997). A recent 
serological survey of 796 children, aged between 1 and 15 years, in Gambia identified C. 
burnetii antibodies in 8.3% (van der Hoek et al., 2013). Intriguingly, they observed that C. 
burnetii seroprevalence was highest among young children (under 4 years), compared with 
other age groups; however, the reasons for this are still unclear. 
Several studies have suggested that Q fever is an important cause of acute fever and 
pneumonia. C. burnetii was identified as the aetiological agent in 5 % of 109 severe pneumonia 
cases in Tanzania (Rubach et al., 2015). Again in Tanzania, an investigation of febrile patients 
identified bacterial zoonoses as the underlying cause in 26.2 % of cases, of which 30 % were 
diagnosed as Q fever (Crump et al., 2013). Within the same patient cohort, malaria was the 
clinical diagnosis in 60.7% cases, whereas laboratory testing confirmed the diagnosis in only 
1.6% of patients. Similarly, Q fever was identified in 8.9 % of paediatric febrile admissions in 
western Kenya (Maina et al., 2016).  Q fever was also identified in  2 % and 9 % of acute 
hospital admissions across two patient cohort studies of febrile admissions in Tunisia (Kaabia 
et al., 2006; Omezzine-Letaief et al., 2004), Q fever was diagnosed in 9 % of community-
acquired pneumonia cases in Cameroon, demonstrating C. burnetii as the second most common 
etiologic agent of pneumonia, after Streptococcus pneumoniae and of equal prevalence as 
Mycoplasma pneumonia (Koulla-Shiro et al., 1997). While the effects of acute infection have 
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been established in several countries, the impact of chronic Q fever in Africa remains largely 
unexplored. However, in the North African country of Algeria, C. burnetii was identified as 
the cause of 3 % (2/77) of infective endocarditis cases analysed (Benslimani et al., 2005). 
 
3.2 Prevalence in Livestock 
Coxiella burnetii is endemic in cattle, sheep, goats, buffaloes and camels across the 
African continent, though there are significant regional differences, even within countries. In a 
recent serological survey of 2,699 animals across Egypt, significant inter-species and regional 
variation was observed (Klemmer et al., 2018). Significantly, camels exhibited the highest rates 
of seropositivity (40.7%), followed by cattle (19.3%), buffalo (11.2%), sheep (8.9%) and goats 
(6.8%). Whereas the highest rates of seropositive animals were observed in the Eastern desert 
(27%), compared to the Nile Delta (16.4%) or Western Desert (17%). Significantly, pasture 
based production systems also had lower levels of seropositive animals (9.9%) compared with 
either Nomadic (19.4%) or stationary husbandry. Similarly, nomadic pastoralism was 
associated with a higher prevalence of C. burnetii seropositivity in small ruminants in Baringo 
County, Kenya (Muema et al., 2017). Camels appear to consistently exhibit high rates of 
seroprevalence. In Algeria, C. burnetii seroprevalence was determined as 71.2% in camels, 
with age, increased herd size and tick infestation identified as risk factors (Benaissa et al., 
2017). Again, despite a lower overall seroprevalence of 18.6%, camel age was determined to 
be a significant risk factor for C. burnetii infection in Laikipia County in Kenya. A further 
study in Chad also demonstrated 80% seroprevalence in camels, compared to only 4% in cattle, 
13% in goats and 11% in sheep (Schelling et al., 2003).  
Serology provides evidence of the exposure of livestock to C. burnetii but can only 
provide limited data on the risk of clinical disease. There are however, few published African 
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studies that have directly investigated C. burnetii in ruminant abortion. In Niger, 32% of goats 
with prior history of abortion were found to be seropositive for C. burnetii compared with 29% 
of non-randomly selected goats without abortion (Haumesser and Poutrel, 1973). Likewise, C. 
burnetii positivity was a significant risk factor for cattle abortion in Northern Togo (Dean et 
al., 2013). In South Africa, C. burnetii was observed in aborted lamb foetuses by microscopy 
(Schutte et al., 1976). C. burnetii DNA was identified in the placenta and vaginal swab sample 
from one aborted goat sample in a study of 109 abortions from Egyptian dairy goats, sheep and 
cattle (Abdel-Moein and Hamza, 2017). In Tunisia, C. burnetii DNA was found in the birth 
products or vaginal secretions of 19% of small ruminants with a history of abortion (Berri et 
al., 2009). 
 
3.3 Livestock and human cross infection 
A number of studies have associated livestock production as a significant risk factor for 
the acquisition of Q fever by humans. Direct evidence was provided in a recent study of small 
ruminants and humans in Gambia, which identified that the presence of a C. burnetii positive 
animal in a compound was a significant risk factor in human infection(Bok et al., 2017). 
Exposure to cattle, goats, animal slaughter or the consumption of raw milk products were 
identified risk factors for C. burnetii seropositivity in febrile hospital patients in Northern 
Kenya (Njeru et al., 2016). In Northern Togo C. burnetii seropositivity was found to be higher 
in Fulani pastoralists (45 %) than in non-Fulani (27 %) (Dean et al., 2013), and in Chad, 
working as a Camel breeder was significantly associated with a positive C. burnetii antibody 
titre (Schelling et al., 2003). In a multi-national study across Africa, higher rates of 
seropositivity were observed in Mali, Burkina Faso, Nigeria and the Central African Republic, 
which were the countries under study, exhibited highest densities of ruminants (>100/ humans) 
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(Dupont et al., 1995). A study of Egyptians in close contact with animals also reported a high 
overall seroprevalence (16 %) with greater seropositivity among rural (22 %) vs. urban (4 %) 
residents (Nahed and Khaled, 2012). Similarly, being a rural inhabitant was a significant risk 
factor for C. burnetii seropositivity in an agro pastoral region of Algeria (Lacheheb and Raoult, 
2009).  
 
4. The importance of Genotype in understanding the epidemiology of infection Q fever 
Bacterial genotyping is a key tool in epidemiological investigations, allowing the 
discrimination of isolates from different sources and thus identify the potential source of 
infection. Genotyping studies have revealed genetic variability in C. burnetii isolates which 
may exhibit different degrees of pathogenicity or confer host specificity. Genotyping of human 
and livestock isolates proved effective in identifying the source of human clinical infections 
during the Netherlands’ outbreak (Tilburg et al., 2012a; Tilburg et al., 2012b), which allowed 
the development of strategies to control the transmission of infection to the human population. 
4.1 Genotyping in Europe  
Multi locus variable-number tandem repeat (VNTR) analysis (MLVA) has become an 
established typing technique for a number of bacterial species. Up to 17 different genomic 
target-regions can be used to discriminate between C. burnetii strains, (Arricau-Bouvery et al., 
2006; Svraka et al., 2006). MLVA was used to identify a dominant C. burnetii genotype 
circulating within the goat and sheep population during the Netherlands’ outbreak, initially 
using a panel of 3-loci, before a 10-loci MLVA panel was developed (Tilburg et al., 2012a). 
While a study in human clinical samples used a different set of markers (Tilburg et al., 2012b), 
alleles in the four overlapping markers were identical, implicating goats and sheep as the 
possible source of the outbreak. While MLVA analysis initially defined goats as the source of 
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human infection during the Netherlands’ outbreak, it was subsequently confirmed by 
Multispacer sequence typing (MST). The MST method is based upon the analysis of the 
intergenic regions of genomes. These non-coding regions are not subject to the same selection 
pressures as the coding regions and are therefore considered to be stable elements of the 
genome.  
An MST typing methodology based upon 10 highly variable spacers was first 
developed in 2005 (Glazunova et al., 2005) and used to separate 173 isolates into 30 discrete 
genotypes. A modification of the MST method, real-time PCR protocols to analyse of single 
nucleotide polymorphisms (SNPs) within the MST loci has also been developed, and used 
extensively in the USA (Hornstra et al., 2011). MST has shown itself to be a useful tool in both 
the epidemic situation, but also due to its the widespread use the techniques has allowed direct 
genotypic comparisons of C. burnetii isolates to be made across different host reservoirs 
throughout the world. In the Netherlands’ outbreak, MST33 was identified in both goats and 
human clinical cases of infection, demonstrating that goats were the probable source of the 
epidemic (Tilburg et al., 2012a). Further phylogenetic analysis suggested that MST33 genotype 
may have originated from Germany and entered the Netherlands via France. Conversely, in 
cattle where C. burnetii is endemic, the dominant genotype identified in the Netherlands was 
MST20. The genotype has been identified extensively in cattle populations, particularly in the 
USA where the ST20 is the dominant genotype and has been identified in 95.9% of genotyped 
bulk milk samples, and is not thought to pose a risk to human health (Bauer et al., 2015).  While 
apparently being a cattle adapted genotype (Olivas et al., 2016), and not apparently the source 
of human disease during the Netherlands’ outbreak or in the USA, MST 20 (MLVA I and J) 
has also been identified in a range of clinical conditions in both humans and animals. These 
include the presence in human heart valves from France, sheep and goat abortions in the 
Netherlands (Tilburg et al., 2012a) and UK (Reichel et al., 2012), and cattle abortions in 
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Hungary (Sulyok et al., 2014b). This apparent discrepancy in pathogenicity and host range 
between organisms of the same genotype in different geographical locations suggests that 
despite our current levels of understanding of C. burnetii epidemiology, further understanding 
of local circulating genotypes and/ or greater discriminatory power of genotyping analysis is 
still required to understand the disease causing potential of the organism in different host 
species.  
The complex nature of circulating C. burnetii genotypes within different host species 
has been examined using a different SNP genotyping protocol, which was developed by a 
Dutch group during the Netherlands’ outbreak (Huijsmans et al., 2011). A total of 10 SNPs 
were analysed in a total of 14 human and 26 livestock derived samples, using a real-time PCR 
protocol. This analysis identified 5 distinct genotypes circulating in human and animal 
populations. The protocol has been used in a number of livestock studies in in Belgium and the 
USA (Boarbi et al., 2014; Mori et al., 2013; Pearson et al., 2014), the results suggesting a 
greater degree of variability in circulating C. burnetii genotypes in goat populations, but much 
less variability in the genotypes found in cattle. However the significance of this remains to be 
elucidated.  
 
4.2 Coxiella burnetii genotypes in Africa 
An investigation of the available literature on current C. burnetii genotyping techniques (SNP, 
MST, VNTR, MLVA), via PubMed (https://www.ncbi.nlm.nih.gov/pubmed) and Web of 
Science (https://wok.mimas.ac.uk/) identified relatively few genotyping studies which have 
been conducted in Africa (summarised in Figure 1).  
Up to 10 distinct MST genotypes have been identified from various hosts (although most are 
from ticks) and countries. Genotypes MST 2, 6, 16 and 19 have been detected so far in humans 
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(Hornstra et al., 2011; Mediannikov et al., 2010; Sulyok et al., 2014b). Other hosts include 
cattle (Rahal et al., 2018), goats (Walter et al., 2014), dogs, rodents (Chitanga et al., 2018) and 
louse (Louni et al., 2018a; Louni et al., 2018b). While some genotypes (2, 30, and 52) are 
unique to Africa (Glazunova et al., 2005; Sulyok et al., 2014b), others including MST16 
(Sulyok et al., 2014a) and MST20 (Hornstra et al., 2011; Kumsa et al., 2015; Rahal et al., 2018) 
have been shown to be related to strains from other non-African countries. In addition to the 
MST data MLVA-typing data is available for two strains from Africa (Morocco and Namibia) 
showing a distinct pattern with unique regional genotypes (Arricau-Bouvery et al., 2006; 
Walter et al., 2014). 
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Figure 1: Various C. burnetii genotypes identified in Africa. The different colors indicates 
different genotypes and the shape of the ribbon is indicative of the host; circle (tick), star 
(human), square (louse), triangle (dogs/rodents). The Namibian isolate is from a goat. 
 
5. Future directions 
There is still a relative paucity of knowledge about C. burnetii prevalence and the clinical 
importance of Q fever in both humans and animals across Africa. The majority of studies to 
date across the African subcontinent have relied solely on serology. While this data is 
informative in terms of understanding the exposure of populations to the organism, it is of 
limited use on its own in terms of epidemiological studies, and source tracking information. 
Much of our current knowledge on Q fever epidemiology is based upon the experience of the 
Netherlands’ outbreak. Here, genotyping proved significant and effective in identifying goats 
as the definitive source of human infection. This data has been subsequently used to model risk 
factors and transmission. However, it would be naïve for us to assume that such models of risk, 
based on Northern European farming practices and climate can be extrapolated across the 
African continent or even between individual African countries.  To date there has been limited 
genotyping of C. burnetii samples across Africa, and studies utilizing genotyping have been 
skewed towards MST analysis of individual human infections and tick populations (see Figure 
1). While livestock infections are largely underrepresented in molecular analysis, the presence 
of MST20 in Algerian cattle abortions is an important observation (Rahal et al., 2018). 
However, on its own this is an important observation, but as previously highlighted will only 
be of limited value unless put into a wider regional context in human and animal health. Given 
our knowledge of the transmission of C. burnetii and differences in the apparent pathogenicity 
of different genotypes in human and animal populations, the long-term focus must be on 
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integrating serological and molecular genotypic data. Only then will we be able to differentiate 
between the transmission of C. burnetii and the risks of Q fever.  
 
Conflict of interest 
The authors declare that they have no conflict of interest. 
 
Acknowledgements 
The authors would like to thank Edinburgh Napier University (Research Grant N5036) for their 
funding support. 
 
 
References 
1. Abdel-Moein, K.A., Hamza, D.A., 2017. The burden of Coxiella burnetii among 
aborted dairy animals in Egypt and its public health implications. Acta tropica 166, 92-
95. 
2. Amit, S., Shinar, S., Halutz, O., Atiya-Nasagi, Y., Giladi, M., 2014. Suspected person-
to-person transmission of Q fever among hospitalized pregnant women. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of 
America 58, e146-147. 
3. Arricau-Bouvery, N., Hauck, Y., Bejaoui, A., Frangoulidis, D., Bodier, C.C., Souriau, 
A., Meyer, H., Neubauer, H., Rodolakis, A., Vergnaud, G., 2006. Molecular 
AC
CE
PT
D M
AN
US
CR
IPT
19 
 
characterization of Coxiella burnetii isolates by infrequent restriction site-PCR and 
MLVA typing. BMC microbiology 6, 38. 
4. Arricau-Bouvery, N., Souriau, A., Bodier, C., Dufour, P., Rousset, E., Rodolakis, A., 
2005. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in 
pregnant goats. Vaccine 23, 4392-4402. 
5. Barkallah, M., Gharbi, Y., Hassena, A.B., Slima, A.B., Mallek, Z., Gautier, M., Greub, 
G., Gdoura, R., Fendri, I., 2014. Survey of infectious etiologies of bovine abortion 
during mid- to late gestation in dairy herds. PloS one 9, e91549. 
6. Bauer, A.E., Olivas, S., Cooper, M., Hornstra, H., Keim, P., Pearson, T., Johnson, A.J., 
2015. Estimated herd prevalence and sequence types of Coxiella burnetii in bulk tank 
milk samples from commercial dairies in Indiana. BMC veterinary research 11, 186. 
7. Benaissa, M.H., Ansel, S., Mohamed-Cherif, A., Benfodil, K., Khelef, D., Youngs, 
C.R., Kaidi, R., Ait-Oudhia, K., 2017. Seroprevalence and risk factors for Coxiella 
burnetii, the causative agent of Q fever in the dromedary camel (Camelus dromedarius) 
population in Algeria. The Onderstepoort journal of veterinary research 84, e1-e7. 
8. Benslimani, A., Fenollar, F., Lepidi, H., Raoult, D., 2005. Bacterial zoonoses and 
infective endocarditis, Algeria. Emerging infectious diseases 11, 216-224. 
9. Berri, M., Rekiki, A., Boumedine, K.S., Rodolakis, A., 2009. Simultaneous differential 
detection of Chlamydophila abortus, Chlamydophila pecorum and Coxiella burnetii 
from aborted ruminant's clinical samples using multiplex PCR. BMC microbiology 9, 
130. 
10. Berri, M., Souriau, A., Crosby, M., Crochet, D., Lechopier, P., Rodolakis, A., 2001. 
Relationships between the shedding of Coxiella burnetii, clinical signs and serological 
responses of 34 sheep. The Veterinary record 148, 502-505. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
20 
 
11. Boarbi, S., Mori, M., Rousset, E., Sidi-Boumedine, K., Van Esbroeck, M., Fretin, D., 
2014. Prevalence and molecular typing of Coxiella burnetii in bulk tank milk in Belgian 
dairy goats, 2009-2013. Veterinary microbiology 170, 117-124. 
12. Bok, J., Hogerwerf, L., Germeraad, E.A., Roest, H.I., Faye-Joof, T., Jeng, M., 
Nwakanma, D., Secka, A., Stegeman, A., Goossens, B., Wegmuller, R., van der Sande, 
M.A., van der Hoek, W., Secka, O., 2017. Coxiella burnetii (Q fever) prevalence in 
associated populations of humans and small ruminants in The Gambia. Tropical 
medicine & international health : TM & IH 22, 323-331. 
13. Buhariwalla, F., Cann, B., Marrie, T.J., 1996. A dog-related outbreak of Q fever. 
Clinical infectious diseases : an official publication of the Infectious Diseases Society 
of America 23, 753-755. 
14. Ceglie, L., Guerrini, E., Rampazzo, E., Barberio, A., Tilburg, J.J., Hagen, F., Lucchese, 
L., Zuliani, F., Marangon, S., Natale, A., 2015. Molecular characterization by MLVA 
of Coxiella burnetii strains infecting dairy cows and goats of north-eastern Italy. 
Microbes and infection 17, 776-781. 
15. Chitanga, S., Simulundu, E., Simuunza, M.C., Changula, K., Qiu, Y., Kajihara, M., 
Nakao, R., Syakalima, M., Takada, A., Mweene, A.S., Mukaratirwa, S., Hang'ombe, 
B.M., 2018. First molecular detection and genetic characterization of Coxiella burnetii 
in Zambian dogs and rodents. Parasites & vectors 11, 40. 
16. Corwin, A., Habib, M., Watts, D., Darwish, M., Olson, J., Botros, B., Hibbs, R., 
Kleinosky, M., Lee, H.W., Shope, R., et al., 1993. Community-based prevalence profile 
of arboviral, rickettsial, and Hantaan-like viral antibody in the Nile River Delta of 
Egypt. The American journal of tropical medicine and hygiene 48, 776-783. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
21 
 
17. Crump, J.A., 2014. Time for a comprehensive approach to the syndrome of fever in the 
tropics. Transactions of the Royal Society of Tropical Medicine and Hygiene 108, 61-
62. 
18. Crump, J.A., Morrissey, A.B., Nicholson, W.L., Massung, R.F., Stoddard, R.A., 
Galloway, R.L., Ooi, E.E., Maro, V.P., Saganda, W., Kinabo, G.D., Muiruri, C., 
Bartlett, J.A., 2013. Etiology of severe non-malaria febrile illness in Northern Tanzania: 
a prospective cohort study. PLoS neglected tropical diseases 7, e2324. 
19. Davis, G.E., Cox, H.R., Parker, R.R., Dyer, R.E., 1938. A Filter-Passing Infectious 
Agent Isolated from Ticks. I. Isolation from Dermacentor andersonii, reactions with 
animals, and filtration experiments. Public Health Reports 53, 2259-2282. 
20. Davoust, B., Marie, J.L., Pommier de Santi, V., Berenger, J.M., Edouard, S., Raoult, 
D., 2014. Three-toed sloth as putative reservoir of Coxiella burnetii, Cayenne, French 
Guiana. Emerging infectious diseases 20, 1760-1761. 
21. Dean, A.S., Bonfoh, B., Kulo, A.E., Boukaya, G.A., Amidou, M., Hattendorf, J., Pilo, 
P., Schelling, E., 2013. Epidemiology of brucellosis and q Fever in linked human and 
animal populations in northern togo. PloS one 8, e71501. 
22. Derrick, E.H., 1937.   " Q " Fever, a New Fever Entity : Clinical Features, Diagnosis 
and Laboratory Investigation. Medical Journal of Australia  2, 281-299. 
23. Derrick, E.H., 1973. The course of infection with Coxiella burneti. The Medical journal 
of Australia 1, 1051-1057. 
24. Dupont, H.T., Brouqui, P., Faugere, B., Raoult, D., 1995. Prevalence of antibodies to 
Coxiella burnetti, Rickettsia conorii, and Rickettsia typhi in seven African countries. 
Clinical infectious diseases : an official publication of the Infectious Diseases Society 
of America 21, 1126-1133. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
22 
 
25. Eldin, C., Angelakis, E., Renvoise, A., Raoult, D., 2013. Coxiella burnetii DNA, but 
not viable bacteria, in dairy products in France. The American journal of tropical 
medicine and hygiene 88, 765-769. 
26. Eldin, C., Mahamat, A., Djossou, F., Raoult, D., 2015. Rainfall and sloth births in may, 
Q fever in July, Cayenne, French Guiana. The American journal of tropical medicine 
and hygiene 92, 979-981. 
27. Eldin, C., Melenotte, C., Mediannikov, O., Ghigo, E., Million, M., Edouard, S., Mege, 
J.L., Maurin, M., Raoult, D., 2017. From Q Fever to Coxiella burnetii Infection: a 
Paradigm Change. Clinical microbiology reviews 30, 115-190. 
28. Gale, P., Kelly, L., Mearns, R., Duggan, J., Snary, E.L., 2015. Q fever through 
consumption of unpasteurised milk and milk products - a risk profile and exposure 
assessment. Journal of applied microbiology 118, 1083-1095. 
29. Gikas, A., Kokkini, S., Tsioutis, C., 2010. Q fever: clinical manifestations and 
treatment. Expert review of anti-infective therapy 8, 529-539. 
30. Glazunova, O., Roux, V., Freylikman, O., Sekeyova, Z., Fournous, G., Tyczka, J., 
Tokarevich, N., Kovacava, E., Marrie, T.J., Raoult, D., 2005. Coxiella burnetii 
genotyping. Emerging infectious diseases 11, 1211-1217. 
31. Guatteo, R., Seegers, H., Taurel, A.F., Joly, A., Beaudeau, F., 2011. Prevalence of 
Coxiella burnetii infection in domestic ruminants: a critical review. Veterinary 
microbiology 149, 1-16. 
32. Hatchette, T., Campbell, N., Hudson, R., Raoult, D., Marrie, T.J., 2003. Natural history 
of Q fever in goats. Vector borne and zoonotic diseases (Larchmont, N.Y.) 3, 11-15. 
33. Haumesser, J.B., Poutrel, B., 1973. [Rickettsiosis in Niger. Epidemiological survey 
conducted in the Maradi region]. Revue d'elevage et de medecine veterinaire des pays 
tropicaux 26, 293-298. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
23 
 
34. Hornstra, H.M., Priestley, R.A., Georgia, S.M., Kachur, S., Birdsell, D.N., Hilsabeck, 
R., Gates, L.T., Samuel, J.E., Heinzen, R.A., Kersh, G.J., Keim, P., Massung, R.F., 
Pearson, T., 2011. Rapid typing of Coxiella burnetii. PloS one 6, e26201. 
35. Huijsmans, C.J., Schellekens, J.J., Wever, P.C., Toman, R., Savelkoul, P.H., Janse, I., 
Hermans, M.H., 2011. Single-nucleotide-polymorphism genotyping of Coxiella 
burnetii during a Q fever outbreak in The Netherlands. Applied and environmental 
microbiology 77, 2051-2057. 
36. Julvez, J., Michault, A., Kerdelhue, C., 1997. [Serological study of rickettsia infections 
in Niamey, Niger]. Medecine tropicale : revue du Corps de sante colonial 57, 153-156. 
37. Kaabia, N., Rolain, J.M., Khalifa, M., Ben Jazia, E., Bahri, F., Raoult, D., Letaief, A., 
2006. Serologic study of rickettsioses among acute febrile patients in central Tunisia. 
Annals of the New York Academy of Sciences 1078, 176-179. 
38. Kampschreur, L.M., Wegdam-Blans, M.C., Thijsen, S.F., Groot, C.A., Schneeberger, 
P.M., Hollander, A.A., Schijen, J.H., Arents, N.L., Oosterheert, J.J., Wever, P.C., 2010. 
Acute Q fever related in-hospital mortality in the Netherlands. The Netherlands journal 
of medicine 68, 408-413. 
39. Kaplan, M.M., Bertagna, P., 1955. The geographical distribution of Q fever. Bulletin 
of the World Health Organization 13, 829-860. 
40. Kersh, G.J., Fitzpatrick, K.A., Self, J.S., Priestley, R.A., Kelly, A.J., Lash, R.R., 
Marsden-Haug, N., Nett, R.J., Bjork, A., Massung, R.F., Anderson, A.D., 2013a. 
Presence and persistence of Coxiella burnetii in the environments of goat farms 
associated with a Q fever outbreak. Applied and environmental microbiology 79, 1697-
1703. 
41. Kersh, G.J., Priestley, R., Massung, R.F., 2013b. Stability ofCoxiella burnetii in stored 
human blood. Transfusion 53, 1493-1496. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
24 
 
42. Klemmer, J., Njeru, J., Emam, A., El-Sayed, A., Moawad, A.A., Henning, K., 
Elbeskawy, M.A., Sauter-Louis, C., Straubinger, R.K., Neubauer, H., El-Diasty, M.M., 
2018. Q fever in Egypt: Epidemiological survey of Coxiella burnetii specific antibodies 
in cattle, buffaloes, sheep, goats and camels. PloS one 13, e0192188. 
43. Kobbe, R., Kramme, S., Kreuels, B., Adjei, S., Kreuzberg, C., Panning, M., Adjei, O., 
Fleischer, B., May, J., 2008. Q fever in young children, Ghana. Emerging infectious 
diseases 14, 344-346. 
44. Komiya, T., Sadamasu, K., Toriniwa, H., Kato, K., Arashima, Y., Fukushi, H., Hirai, 
K., Arakawa, Y., 2003. Epidemiological survey on the route of Coxiella burnetii 
infection in an animal hospital. Journal of infection and chemotherapy : official journal 
of the Japan Society of Chemotherapy 9, 151-155. 
45. Kopecny, L., Bosward, K.L., Shapiro, A., Norris, J.M., 2013. Investigating Coxiella 
burnetii infection in a breeding cattery at the centre of a Q fever outbreak. Journal of 
feline medicine and surgery 15, 1037-1045. 
46. Kosatsky, T., 1984. Household outbreak of Q fever pneumonia related to a parturient 
cat. Lancet (London, England) 2, 1447-1449. 
47. Koulla-Shiro, S., Kuaban, C., Belec, L., 1997. Microbial etiology of acute community-
acquired pneumonia in adult hospitalized patients in Yaounde-Cameroon. Clinical 
microbiology and infection : the official publication of the European Society of Clinical 
Microbiology and Infectious Diseases 3, 180-186. 
48. Kumsa, B., Socolovschi, C., Almeras, L., Raoult, D., Parola, P., 2015. Occurrence and 
Genotyping of Coxiella burnetii in Ixodid Ticks in Oromia, Ethiopia. The American 
journal of tropical medicine and hygiene 93, 1074-1081. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
25 
 
49. Lacheheb, A., Raoult, D., 2009. Seroprevalence of Q fever in Algeria. Clinical 
microbiology and infection : the official publication of the European Society of Clinical 
Microbiology and Infectious Diseases 15 Suppl 2, 167-168. 
50. Lang, G., Waltner-Toews, D., Menzies, P., 1991. The seroprevalence of coxiellosis (Q 
fever) in Ontario sheep flocks. Canadian journal of veterinary research = Revue 
canadienne de recherche veterinaire 55, 139-142. 
51. Langley, J.M., Marrie, T.J., Covert, A., Waag, D.M., Williams, J.C., 1988. Poker 
players' pneumonia. An urban outbreak of Q fever following exposure to a parturient 
cat. The New England journal of medicine 319, 354-356. 
52. Laughlin, T., Waag, D., Williams, J., Marrie, T., 1991. Q fever: from deer to dog to 
man. Lancet (London, England) 337, 676-677. 
53. Louni, M., Amanzougaghene, N., Mana, N., Fenollar, F., Raoult, D., Bitam, I., 
Mediannikov, O., 2018a. Detection of bacterial pathogens in clade E head lice collected 
from Niger's refugees in Algeria. Parasites & vectors 11, 348. 
54. Louni, M., Mana, N., Bitam, I., Dahmani, M., Parola, P., Fenollar, F., Raoult, D., 
Mediannikov, O., 2018b. Body lice of homeless people reveal the presence of several 
emerging bacterial pathogens in northern Algeria.  12, e0006397. 
55. Maina, A.N., Farris, C.M., Odhiambo, A., Jiang, J., Laktabai, J., Armstrong, J., 
Holland, T., Richards, A.L., O'Meara, W.P., 2016. Q Fever, Scrub Typhus, and 
Rickettsial Diseases in Children, Kenya, 2011-2012. Emerging infectious diseases 22, 
883-886. 
56. Malo, J.A., Colbran, C., Young, M., Vasant, B., Jarvinen, K., Viney, K., Lambert, S.B., 
2018. An outbreak of Q fever associated with parturient cat exposure at an animal 
refuge and veterinary clinic in southeast Queensland. Australian and New Zealand 
journal of public health. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
26 
 
57. Marrie, T.J., MacDonald, A., Durant, H., Yates, L., McCormick, L., 1988. An outbreak 
of Q fever probably due to contact with a parturient cat. Chest 93, 98-103. 
58. Maurin, M., Raoult, D., 1999. Q fever. Clinical microbiology reviews 12, 518-553. 
59. Mediannikov, O., Fenollar, F., Socolovschi, C., Diatta, G., Bassene, H., Molez, J.F., 
Sokhna, C., Trape, J.F., Raoult, D., 2010. Coxiella burnetii in humans and ticks in rural 
Senegal. PLoS neglected tropical diseases 4, e654. 
60. Milazzo, A., Hall, R., Storm, P.A., Harris, R.J., Winslow, W., Marmion, B.P., 2001. 
Sexually transmitted Q fever. Clinical infectious diseases : an official publication of the 
Infectious Diseases Society of America 33, 399-402. 
61. Mori, M., Boarbi, S., Michel, P., Bakinahe, R., Rits, K., Wattiau, P., Fretin, D., 2013. 
In vitro and in vivo infectious potential of Coxiella burnetii: a study on Belgian 
livestock isolates. PloS one 8, e67622. 
62. Mori, M., Roest, H.J., 2018. Farming, Q fever and public health: agricultural practices 
and beyond. Archives of public health = Archives belges de sante publique 76, 2. 
63. Morroy, G., Van Der Hoek, W., Nanver, Z.D., Schneeberger, P.M., Bleeker-Rovers, 
C.P., Van Der Velden, J., Coutinho, R.A., 2016. The health status of a village 
population, 7 years after a major Q fever outbreak. Epidemiology and infection 144, 
1153-1162. 
64. Muema, J., Thumbi, S.M., Obonyo, M., Wanyoike, S., Nanyingi, M., Osoro, E., Bitek, 
A., Karanja, S., 2017. Seroprevalence and Factors Associated with Coxiella burnetii 
Infection in Small Ruminants in Baringo County, Kenya. Zoonoses and public health 
64, e31-e43. 
65. Nahed, H.G., Khaled, A.A.M., 2012. Seroprevalence of Coxiella burnetii antibodies 
among farm animal and human contacts in Egypt. J Am Sci 8, 619-621. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
27 
 
66. Njeru, J., Henning, K., Pletz, M.W., Heller, R., Forstner, C., Kariuki, S., Fevre, E.M., 
Neubauer, H., 2016. Febrile patients admitted to remote hospitals in Northeastern 
Kenya: seroprevalence, risk factors and a clinical prediction tool for Q fever. BMC 
infectious diseases 16, 244. 
67. Nusinovici, S., Hoch, T., Brahim, M.L., Joly, A., Beaudeau, F., 2017. The Effect of 
Wind onCoxiella burnetii Transmission Between Cattle Herds: a Mechanistic 
Approach. Transboundary and emerging diseases 64, 585-592. 
68. Oei, W., Kretzschmar, M.E., Zaaijer, H.L., Coutinho, R., van der Poel, C.L., Janssen, 
M.P., 2014. Estimating the transfusion transmission risk of Q fever. Transfusion 54, 
1705-1711. 
69. Olivas, S., Hornstra, H., Priestley, R.A., Kaufman, E., Hepp, C., Sonderegger, D.L., 
Handady, K., Massung, R.F., Keim, P., Kersh, G.J., Pearson, T., 2016. Massive 
dispersal ofCoxiella burnetii among cattle across the United States. Microbial genomics 
2, e000068. 
70. Omezzine-Letaief, A., Alaoui, F.Z., Bahri, F., Mahdhaoui, A., Boughzela, E., Jemni, 
L., 2004. [Infectious endocarditis with negative blood cultures]. Archives des maladies 
du coeur et des vaisseaux 97, 120-124. 
71. Pearson, T., Hornstra, H.M., Hilsabeck, R., Gates, L.T., Olivas, S.M., Birdsell, D.M., 
Hall, C.M., German, S., Cook, J.M., Seymour, M.L., Priestley, R.A., Kondas, A.V., 
Clark Friedman, C.L., Price, E.P., Schupp, J.M., Liu, C.M., Price, L.B., Massung, R.F., 
Kersh, G.J., Keim, P., 2014. High prevalence and two dominant host-specific genotypes 
ofCoxiella burnetii in U.S. milk. BMC microbiology 14, 41. 
72. Pinsky, R.L., Fishbein, D.B., Greene, C.R., Gensheimer, K.F., 1991. An outbreak of 
cat-associated Q fever in the United States. The Journal of infectious diseases 164, 202-
204. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
28 
 
73. Rahal, M., Tahir, D., Eldin, C., Bitam, I., Raoult, D., Parola, P., 2018. Genotyping of 
Coxiella burnetii detected in placental tissues from aborted dairy cattle in the north of 
Algeria. Comparative immunology, microbiology and infectious diseases 57, 50-54. 
74. Raoult, D., Marrie, T., Mege, J., 2005. Natural history and pathophysiology of Q fever. 
The Lancet. Infectious diseases 5, 219-226. 
75. Raoult, D., Stein, A., 1994. Q fever during pregnancy--a risk for women, fetuses, and 
obstetricians. The New England journal of medicine 330, 371. 
76. Reichel, R., Mearns, R., Brunton, L., Jones, R., Horigan, M., Vipond, R., Vincent, G., 
Evans, S., 2012. Description of a Coxiella burnetii abortion outbreak in a dairy goat 
herd, and associated serology, PCR and genotyping results. Research in veterinary 
science 93, 1217-1224. 
77. Roest, H.J., van Gelderen, B., Dinkla, A., Frangoulidis, D., van Zijderveld, F., Rebel, 
J., van Keulen, L., 2012. Q fever in pregnant goats: pathogenesis and excretion of 
Coxiella burnetii. PloS one 7, e48949. 
78. Rousset, E., Durand, B., Champion, J.L., Prigent, M., Dufour, P., Forfait, C., Marois, 
M., Gasnier, T., Duquesne, V., Thiery, R., Aubert, M.F., 2009. Efficiency of a phase 1 
vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected 
goat herd. Clinical microbiology and infection : the official publication of the European 
Society of Clinical Microbiology and Infectious Diseases 15 Suppl 2, 188-189. 
79. Rubach, M.P., Maro, V.P., Bartlett, J.A., Crump, J.A., 2015. Etiologies of illness 
among patients meeting integrated management of adolescent and adult illness district 
clinician manual criteria for severe infections in northern Tanzania: implications for 
empiric antimicrobial therapy. The American journal of tropical medicine and hygiene 
92, 454-462. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
29 
 
80. Schelling, E., Diguimbaye, C., Daoud, S., Nicolet, J., Boerlin, P., Tanner, M., Zinsstag, 
J., 2003. Brucellosis and Q fever seroprevalences of nomadic pastoralists and their 
livestock in Chad. Preventive veterinary medicine 61, 279-293. 
81. Schneeberger, P.M., Wintenberger, C., van der Hoek, W., Stahl, J.P., 2014. Q fever in 
the Netherlands - 2007-2010: what we learned from the largest outbreak ever. Medecine 
et maladies infectieuses 44, 339-353. 
82. Schutte, A.P., Kurz, J., Barnard, B.J., Roux, D.J., 1976. Q fever in cattle and sheep in 
Southern Africa. A preliminary report. The Onderstepoort journal of veterinary 
research 43, 129-132. 
83. Siroky, P., Kubelova, M., Modry, D., Erhart, J., Literak, I., Spitalska, E., Kocianova, 
E., 2010. Tortoise tick Hyalomma aegyptium as long term carrier of Q fever agent 
Coxiella burnetii--evidence from experimental infection. Parasitology research 107, 
1515-1520. 
84. Sprong, H., Tijsse-Klasen, E., Langelaar, M., De Bruin, A., Fonville, M., Gassner, F., 
Takken, W., Van Wieren, S., Nijhof, A., Jongejan, F., Maassen, C.B., Scholte, E.J., 
Hovius, J.W., Emil Hovius, K., Spitalska, E., Van Duynhoven, Y.T., 2012. Prevalence 
of Coxiella burnetii in ticks after a large outbreak of Q fever. Zoonoses and public 
health 59, 69-75. 
85. Sulyok, K.M., Hornok, S., Abichu, G., Erdelyi, K., Gyuranecz, M., 2014a. 
Identification of novel Coxiella burnetii genotypes from Ethiopian ticks. PloS one 9, 
e113213. 
86. Sulyok, K.M., Kreizinger, Z., Hornstra, H.M., Pearson, T., Szigeti, A., Dan, A., Balla, 
E., Keim, P.S., Gyuranecz, M., 2014b. Genotyping of Coxiella burnetii from domestic 
ruminants and human in Hungary: indication of various genotypes. BMC veterinary 
research 10, 107. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
30 
 
87. Svraka, S., Toman, R., Skultety, L., Slaba, K., Homan, W.L., 2006. Establishment of a 
genotyping scheme for Coxiella burnetii. FEMS microbiology letters 254, 268-274. 
88. Tilburg, J.J., Roest, H.J., Buffet, S., Nabuurs-Franssen, M.H., Horrevorts, A.M., 
Raoult, D., Klaassen, C.H., 2012a. Epidemic genotype of Coxiella burnetii among 
goats, sheep, and humans in the Netherlands. Emerging infectious diseases 18, 887-
889. 
89. Tilburg, J.J., Rossen, J.W., van Hannen, E.J., Melchers, W.J., Hermans, M.H., van de 
Bovenkamp, J., Roest, H.J., de Bruin, A., Nabuurs-Franssen, M.H., Horrevorts, A.M., 
Klaassen, C.H., 2012b. Genotypic diversity of Coxiella burnetii in the 2007-2010 Q 
fever outbreak episodes in The Netherlands. Journal of clinical microbiology 50, 1076-
1078. 
90. Tissot-Dupont, H., Amadei, M.A., Nezri, M., Raoult, D., 2004. Wind in November, Q 
fever in December. Emerging infectious diseases 10, 1264-1269. 
91. Tissot-Dupont, H., Torres, S., Nezri, M., Raoult, D., 1999. Hyperendemic focus of Q 
fever related to sheep and wind. American journal of epidemiology 150, 67-74. 
92. Van den Brom, R., Santman-Berends, I., Luttikholt, S., Moll, L., Van Engelen, E., 
Vellema, P., 2015a. Bulk tank milk surveillance as a measure to detect Coxiella burnetii 
shedding dairy goat herds in the Netherlands between 2009 and 2014. Journal of dairy 
science 98, 3814-3825. 
93. Van den Brom, R., van Engelen, E., Roest, H.I., van der Hoek, W., Vellema, P., 
2015b.Coxiella burnetii infections in sheep or goats: an opinionated review. Veterinary 
microbiology 181, 119-129. 
94. van der Hoek, W., Morroy, G., Renders, N.H., Wever, P.C., Hermans, M.H., Leenders, 
A.C., Schneeberger, P.M., 2012. Epidemic Q fever in humans in the Netherlands. 
Advances in experimental medicine and biology 984, 329-364. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
31 
 
95. van der Hoek, W., Sarge-Njie, R., Herremans, T., Chisnall, T., Okebe, J., Oriero, E., 
Versteeg, B., Goossens, B., van der Sande, M., Kampmann, B., Nwakanma, D., 2013. 
Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in 
children in The Gambia, West Africa. Tropical medicine & international health : TM 
& IH 18, 850-853. 
96. van Kraaij, M.G., Slot, E., Hogema, B.M., Zaaijer, H.L., 2013. Lookback procedures 
after postdonation notifications during a Q fever outbreak in the Netherlands. 
Transfusion 53, 716-721. 
97. van Leuken, J.P., van de Kassteele, J., Sauter, F.J., van der Hoek, W., Heederik, D., 
Havelaar, A.H., Swart, A.N., 2015. Improved correlation of human Q fever incidence 
to modelledC. burnetii concentrations by means of an atmospheric dispersion model. 
International journal of health geographics 14, 14. 
98. van Moll, P., Baumgartner, W., Eskens, U., Hanichen, T., 1993. Immunocytochemical 
demonstration of Coxiella burnetii antigen in the fetal placenta of naturally infected 
sheep and cattle. Journal of comparative pathology 109, 295-301. 
99. Vanderburg, S., Rubach, M.P., Halliday, J.E., Cleaveland, S., Reddy, E.A., Crump, 
J.A., 2014. Epidemiology of Coxiella burnetii infection in Africa: a OneHealth 
systematic review. PLoS neglected tropical diseases 8, e2787. 
100. Varela-Castro, L., Zuddas, C., Ortega, N., Serrano, E., Salinas, J., Castella, J., 
Castillo-Contreras, R., Carvalho, J., Lavin, S., Mentaberre, G., 2018. On the possible 
role of ticks in the eco-epidemiology ofCoxiella burnetii in a Mediterranean ecosystem. 
PLoS pathogens 9, 687-694. 
101. Velasova, M., Damaso, A., Prakashbabu, B.C., Gibbons, J., Wheelhouse, N., 
Longbottom, D., Van Winden, S., Green, M., Guitian, J., 2017. Herd-level prevalence 
AC
CE
PT
ED
 M
AN
US
CR
IPT
32 
 
of selected endemic infectious diseases of dairy cows in Great Britain. Journal of dairy 
science 100, 9215-9233. 
102. Walter, M.C., Ohrman, C., Myrtennas, K., Sjodin, A., Bystrom, M., Larsson, 
P., Macellaro, A., Forsman, M., Frangoulidis, D., 2014. Genome sequence of Coxiella 
burnetii strain Namibia. Standards in genomic sciences 9, 22. 
103. Wattiau, P., Boldisova, E., Toman, R., Van Esbroeck, M., Quoilin, S., 
Hammadi, S., Tissot-Dupont, H., Raoult, D., Henkinbrant, J.M., Van Hessche, M., 
Fretin, D., 2011. Q fever in Woolsorters, Belgium. Emerging infectious diseases 17, 
2368-2369. 
104. Wegdam-Blans, M.C., Kampschreur, L.M., Delsing, C.E., Bleeker-Rovers, 
C.P., Sprong, T., van Kasteren, M.E., Notermans, D.W., Renders, N.H., Bijlmer, H.A., 
Lestrade, P.J., Koopmans, M.P., Nabuurs-Franssen, M.H., Oosterheert, J.J., 2012. 
Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. The 
Journal of infection 64, 247-259. 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
